In the Pipeline
At Anziva Pharmaceuticals, we are building a portfolio of non opioid, non invasive pain management therapies. Each program is designed to enhance patient outcomes while avoiding the risks of addictive drugs or invasive procedures. By using the FDA 505(b)(2) and OTC Monograph pathways, we accelerate development timelines, lower costs, and bring innovative solutions to patients sooner.
Lead Program: J’Neura™ Knee Pain Patch
J’Neura™ is Anziva’s lead non-opioid pain program: a knee-specific transdermal patch being developed for chronic knee pain, including knee osteoarthritis-related pain.
Why Knee Pain?
Knee pain is one of the most common chronic musculoskeletal conditions, yet most topical patches are not designed specifically for the knee joint. Existing creams, gels, and general-purpose patches can be limited by messiness, application burden, poor fit, or lack of knee-specific design.
J’Neura is being developed to address this gap.
Product Concept
J’Neura is a flexible transdermal patch designed for localized knee pain relief. The product is being developed around:
- Knee-specific placement and use
- Localized delivery
- Flexible fit during movement
- Strong adhesion and wearability
- Non-opioid pain relief
- Practical regulatory and commercial pathways
Development Status
J’Neura is currently in pre-clinical development. Anziva has generated early formulation and comparative in vitro testing data, with additional development work ongoing.
A confidential data package is available for qualified partners under NDA.
Partnering Opportunity
Anziva is seeking strategic partners for licensing, co-development, commercialization, or acquisition of the J’Neura program.
Pipeline
Back Pain Patch
A sustained-release patch for chronic back pain that provides consistent relief without interfering with mobility or lifestyle.
Migraine Gel
A fast-acting, non invasive option for acute migraine episodes, designed to deliver targeted relief while bypassing the gastrointestinal tract.
Veterinary Pain
Long-acting pain solutions for cats and dogs, designed to reduce dosing frequency and improve compliance.